1,8-dihydroxy-10H-anthracen-9-one;1143-38-0;KBio3_001368;Prestwick_528;1,8-DIHYDROXY-9(10H)-ANTHRACENONE;1,8-Dihydroxyanthracen-9(10H)-one;9(10H)-Anthracenone, 1,8-dihydroxy- (9CI);Anthra-Derm;BRN 2054360;Batridol;CCRIS 628;Chrysodermol;Cignolin;Cigthranol;Dithranol;Dithranolum [INN-Latin];EINECS 214-538-0;NSC 43970;NSC 629313;Psoriacid-Stift;Anthrone, 1,8-dihydroxy-;Spectrum5_000820;Anthralin (USP);D00233;Dithranol (INN);BSPBio_001868;AIDS-048394;Spectrum4_000151;ZINC00000959;KBioSS_000436;1,8-Dihydroxy-9-anthrone;1,8-Dihydroxyanthrone;9(10H)-Anthracenone, 1,8-dihydroxy-;CHEBI:37510;NSC43970;NCGC00091330-02;AIDS048394;D2773_SIGMA;NCI60_004019;DivK1c_000021;Anthraline;KBio2_000436;KBio2_003004;KBio2_005572;SPECTRUM1500127;NINDS_000021;NCGC00091330-03;1,8-dihydroxy-9-anthrane;NSC629313;KBio1_000021;Spectrum2_000111;IDI1_000021;Spectrum_000056;KBioGR_000622;Spectrum3_000304;Anthraderm (TN);SPBio_000122;10608_FLUKA;NCGC00091330-01;InChI=1/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6,15-16H,7H;Anthraderm
1,8-dihydroxy-10H-anthracen-9-one